Previous research has shown that DNA methylation can exert a negative modulation on UBE2S expression in ovarian cancer, rectal adenocarcinoma, testicular germ cell tumor (TGCT), and so on. This evidence concerns the gene UBE2S and testicular germ cell tumor.